Cloudflare (NET: NYSE)

As AI-craze captures markets around the globe, CloudFlare is another company that is riding the wave of the trend. With an impressive range of tools, this company has specifically tailored them to cater to AI companies that demand top-of-the-line security systems for their valuable data. Given that most of the work in the AI industry happens in the cloud, the exceptional services rendered by Cloudflare are essential to the success of these companies. NET’s R2 Storage platform is a fine example of this, with Character.ai, Leonardo.ai, Lexica.art, and SiteGPT.ai among the companies that have taken advantage of its numerous features. But that’s not all. 

Cloudflare also boasts a longstanding partnership with the hugely successful AI and chip-giants, Nvidia. The NVIDIA collaboration alone is a considerable revenue stream for the company. Investors seem to have caught on to this potential, as many are bullish on NET stock, with an upside target set at $100.00-$105.00 as long as the stock remains above the threshold of $55.00-$57.00. It’s clear that Cloudflare has the foresight and ingenuity needed to thrive in our ever-changing technological landscape.

DexCom (DXCM: NASDAQ)

Dexcom is making waves in the healthcare industry with their cutting-edge product, the G7 constant blood-glucose monitoring device. This device promises to drive new streams of revenue for the company, with first quarter sales already showing double-digit growth compared to the previous year. The future is looking bright for Dexcom, as they prepare for around 1,000 new healthcare providers to start prescribing the G7 to patients. Despite the alarming uptrend in blood sugar illnesses like diabetes in the United States, the availability of the G7 device offers hope for better management and care for those affected. 

Management is anticipating substantial revenue growth of between 15-20% for 2023. But even better, the company’s net income had already skyrocketed over 57% in 2022 as compared to the previous year – an impressive accomplishment by any measure. If that wasn’t enough reason to be bullish on DXCM, it’s also worth noting that analysts believe the stock will maintain a strong performance if it remains above the $108.00-$110.00 range for the foreseeable future. With an upside target of $155.00-$160.00, it’s clear that DXCM is in a strong position moving forward.

TOTAL3

If the whole altcoin market (TOTAL3), which excludes ETH, doesn’t increase from its current position at $300 billion, it may revisit the $233.95 billion level, which would indicate a further 25% decrease from this point.

Judging by the state of many altcoins, some of which have hit new lows, there’s a real possibility that the rest of the altcoin index might follow this downward trajectory.

SOL/USDT

SOL is one of the alts that has seen significant volatility over the past year, particularly last Friday night when it was highlighted as a potential security token by the SEC.

Despite this, we remain very bullish on Solana’s technology as a future-oriented protocol.

The Friday night crash took SOL down to a low of approximately $12.90, the lower support region. However, it quickly rebounded to the higher support area and the crucial 0.618 retracement level, measured from the low on December 22 to the high on February 23.

Today’s spot-long entry at $14.92 with a stop loss placed below the 0.618 retracement line would be a good opportunity.